Rebecca B. Singson, M.D., FPOGS
During the recent Asia Oceania (research organization on) Genital Infection & Neoplasia (AOGIN), world experts on the Human Papilloma Virus and cervical cancer gathered from 18 countries to discuss global initiatives on cervical cancer prevention.
In the past 2 decades, substantial progress in our understanding of the natural history of cervical cancer have led us to conclude that a virus called the Human papillomavirus (HPV) is now recognized as the main cause of cervical cancer. 1 There are more than 70 distinct site-specific types (meaning they will grow on one part of the body but not on another). Of these, about 35 types are found in the anus and the genital areas, causing warts and cervical cancer, the most notorious being types 16 and 18. It is a virus acquired through sexual contact and infects the lining cells of the genitalia and can be detected in 5%-40% of women of reproductive age.2 It has been found that infections are relatively short-lived lasting usually 8-10 months.3 This indicates that our bodies are indeed capable of clearing the virus which is why in women over 30 years old, the prevalence drops down to 5-10%. Persistent infections, however, are found in 5-10% in women over 35 years old.4 It is in this group of women who are not able to clear the virus from their bodies that cancer in the cervix now has a chance to progress. The virus is apparently able to thrive in the cells without killing it and without inducing any immunologic reaction from the patient. The body therefore “ignores” the virus allowing it to eventually alter the genetic code of the cells. As a result, the cervix starts multiplying cells which become cancerous after many years.
It is important to understand the risk factors that increase your chances of acquiring the virus as well as the co-existing factors that mediate progression to cancer. In a case-control study of women with invasive cervical cancer in four Latin American countries where they evaluated cervical cancer risk in relation to sexual behavior, histories of specific venereal diseases, and hygiene practices, it was noted that early age at first sexual intercourse and increasing number of sexual partners were associated with significantly increased risk for cervical cancer. Risk increased over twofold among women reporting first intercourse at 14 to 15 years of age compared with those who started after 20 years old.5 An initial pregnancy before 18 yrs. old and multiple pregnancies (over 5) as well as a history of having acquired a sexually transmitted disease (STD) also increase your risk. Having an uncircumcised male partner, cigarette smoking, an impaired immune system (such as AIDS patients), and poor nutrition (diet low on fruits & vegetables and deficient in Vit A, C & folic acid) all increase ones’s risk for cervical cancer. 6
In the
It is vital for us to educate our youth that it is prudent for men as well as women to delay having sex as late as possible. This is because the earlier you engage in sexual intercourse, the higher the chances for having multibple sexual partners which will increase the chances of acquiring the carcinogenic Human Papillomavirus. Men should realize that although the virus does not cause much harm to them in general other than occasionally causing unsightly penile warts, through their sexual practices, they can transmit the virus to their unsuspecting, innocent monogamous sexual partners. Engaging in sex early has also been linked to increased number of early, unwanted pregnancies which can also increase chance for the virus to mutate the genetic code (because of the immunocompromised state during pregnancy) of the cell to promote cervical cancer. The youth must know that promiscuity can be potentially lethal if one acquires the HPV virus or worse, AIDS so sex should be limited to a significant other or to one destined to be a lifetime partner. It might help them to know that choosing a circumcised male partner can also decrease one’s risk for cervical cancer.
The era has arrived where two major pharmaceuticals (GSK and Merck) are already doing human trials on an HPV vaccines in the hope of reducing the risk for cervical cancer. Hopefully in 2 years, at least one of them will receive FDA approval from the U.S and be commercially available. It is hoped that such vaccines would boost an immune response against the development of cancer or even existing tumors. Preliminary trials of the vaccine have shown some promising success. Hopefully, mass vaccinations at around 10 years old before the woman becomes sexually active can someday help to eradicate a deadly cancer from the face of the earth.
1Jan M. M. Walboomers, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology, 189: 1, 12-19.
2 Franco EL, Villa LL, Richardson H, Rohan T, Ferenczy A. Epidemiology of cervical human papillomavirus infection. In: Franco EL, Monsonégo J, editors. New developments in cervical cancer screening and prevention.
3Ho GYF, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-28.
4Shah KV, Howley PM Papillomavirus. In: Fields MN, et al, ed. Fields Virology, 3rd edition,
5Herrero R, et al. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population. Cancer. 1990 Jan 15;65(2):380-6.
6www.emoryhealthcare.org/HealthGate/32624.html
7McCrory DC, Matchar DB, Bastian L, Datta S, Hasselblad V, Hickey J, et al. Evaluation of cervical cytology. Evidence report/technology assessment no 5; AHCPR publ no 99-E010.
No comments:
Post a Comment